Product Images Imatinib Mesylate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Imatinib Mesylate NDC 42292-043 by Mylan Institutional Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a description of Imatinib Mesylate Tablets which are available in a pack of three strips, each containing 10 tablets. The National Drug Code (NDC) for this medication is 42292-043-03. The tablets should be stored within a temperature range of 20°C to 25°C (68°F to 77°F), as specified by the United States Pharmacopeia (USP).*
This is a pharmaceutical product from Mylan, a company based in Rockford, USA. The container is not child-resistant and should be kept out of the reach of children. It provides light-resistance and the lot number and expiration date can be found on the window. It is intended for institutional use only.*
This appears to be a statistical table showing the number of patients with or without progression and discontinuation within a certain medical study or trial. The hazard ratio and log-rank test results are also given. A clear interpretation of these results is not possible without additional context.*
This is a medication package that does not have child-resistant features and is intended for institutional or adult use only. It is advised to keep this product out of reach of children. The package has light-resistant properties and the lot number and expiration date can be identified through a window. The product is manufactured by Mylan located in Rockford, IL.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.